Important Role of Endogenous Nerve Growth Factor Receptor in the Pathogenesis of Hypoxia-Induced Pulmonary Hypertension in Mice

Pulmonary arterial hypertension (PAH) remains a disease with poor prognosis; thus, a new mechanism for PAH treatment is necessary. Circulating nerve growth factor receptor (Ngfr)-positive cells in peripheral blood mononuclear cells are associated with disease severity and the prognosis of PAH patients; however, the role of Ngfr in PAH is unknown. In this study, we evaluated the function of Ngfr using Ngfr gene-deletion (Ngfr−/−) mice. To elucidate the role of Ngfr in pulmonary hypertension (PH), we used Ngfr−/− mice that were exposed to chronic hypoxic conditions (10% O2) for 3 weeks. The development of hypoxia-induced PH was accelerated in Ngfr−/− mice compared to littermate controls. In contrast, the reconstitution of bone marrow (BM) in Ngfr−/− mice transplanted with wild-type BM cells improved PH. Notably, the exacerbation of PH in Ngfr−/− mice was accompanied by the upregulation of pulmonary vascular remodeling-related genes in lung tissue. In a hypoxia-induced PH model, Ngfr gene deletion resulted in PH exacerbation. This suggests that Ngfr may be a key molecule involved in the pathogenesis of PAH.

[1]  F. Soubrier,et al.  Progenitor/Stem Cells in Vascular Remodeling during Pulmonary Arterial Hypertension , 2021, Cells.

[2]  Yusuke Kodama,et al.  Fibrinolytic markers could be useful predictors of severity in patients with pulmonary arterial hypertension: a retrospective study , 2021, Thrombosis Journal.

[3]  S. Kaneko,et al.  Circulating nerve growth factor receptor positive cells are associated with severity and prognosis of pulmonary arterial hypertension , 2021, Pulmonary circulation.

[4]  M. Humbert,et al.  Targeting transforming growth factor-β receptors in pulmonary hypertension , 2020, European Respiratory Journal.

[5]  C. Ruppert,et al.  BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanics , 2019, PLoS biology.

[6]  S. Kaneko,et al.  Sphigosine-1-phosphate receptor 1 promotes neointimal hyperplasia in a mouse model of carotid artery injury. , 2019, Biochemical and biophysical research communications.

[7]  L. Bracci-Laudiero,et al.  NGF and Its Receptors in the Regulation of Inflammatory Response , 2017, International journal of molecular sciences.

[8]  Sally L Elshaer,et al.  Implication of the neurotrophin receptor p75NTR in vascular diseases: beyond the eye , 2017, Expert review of ophthalmology.

[9]  G. Inman,et al.  TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling , 2017, Nature Communications.

[10]  M. Honda,et al.  Altered gene expression in T-cell receptor signalling in peripheral blood leucocytes in acute coronary syndrome predicts secondary coronary events , 2016, Open Heart.

[11]  M. Humbert,et al.  Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary Hypertension. , 2015, American journal of respiratory and critical care medicine.

[12]  I. Komuro,et al.  Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension , 2015, Proceedings of the National Academy of Sciences.

[13]  M. Humbert,et al.  Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. , 2014, Circulation research.

[14]  D. Moertl,et al.  Markers of Thrombogenesis and Fibrinolysis and Their Relation to Inflammation and Endothelial Activation in Patients with Idiopathic Pulmonary Arterial Hypertension , 2013, PloS one.

[15]  H. Ghofrani,et al.  Mechanisms of disease: pulmonary arterial hypertension , 2011, Nature Reviews Cardiology.

[16]  R. Trembath,et al.  Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension , 2010, Circulation.

[17]  S. Eddahibi,et al.  Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice , 2009, Respiratory research.

[18]  A. Görlach,et al.  The ‘PAI-1 paradox’ in vascular remodelling , 2008, Thrombosis and Haemostasis.

[19]  G. Spinetti,et al.  Neurotrophin p75 Receptor (p75NTR) Promotes Endothelial Cell Apoptosis and Inhibits Angiogenesis: Implications for Diabetes-Induced Impaired Neovascularization in Ischemic Limb Muscles , 2008, Circulation research.

[20]  G. Diller,et al.  Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension , 2008, Circulation.

[21]  R. Tuder,et al.  Pathology of pulmonary hypertension. , 2007, Clinics in chest medicine.

[22]  W. Vainchenker,et al.  Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice , 2007, Respiratory research.

[23]  S. Mieno,et al.  Implantation of Mesenchymal Stem Cells Overexpressing Endothelial Nitric Oxide Synthase Improves Right Ventricular Impairments Caused by Pulmonary Hypertension , 2006, Circulation.

[24]  M. Frid,et al.  Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. , 2006, The American journal of pathology.

[25]  Qingbo Xu,et al.  Smooth Muscle Cells in Transplant Atherosclerotic Lesions Are Originated From Recipients, but Not Bone Marrow Progenitor Cells , 2002, Circulation.

[26]  Y. Barde,et al.  Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. , 2000, Genes & development.

[27]  S. Kaneko,et al.  Endogenous muscle atrophy F-box is involved in the development of cardiac rupture after myocardial infarction. , 2019, Journal of molecular and cellular cardiology.